Autotaxin Modulator 1 is primarily utilized in research and therapeutic development targeting the autotaxin enzyme, which plays a critical role in producing lysophosphatidic acid (LPA). LPA is involved in various cellular processes, including proliferation, migration, and survival, making it a key factor in diseases such as cancer, fibrosis, and inflammation. By modulating autotaxin activity, this compound helps in studying the enzyme's role in pathological conditions and potentially developing treatments to inhibit its function. It is particularly valuable in preclinical studies to understand and disrupt the signaling pathways associated with LPA, offering insights into novel therapeutic strategies for conditions like metastatic cancer and chronic inflammatory diseases.